MONTVALE, N.J., May 3 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its first quarter
financial results on Thursday, May 10, 2007, before the U.S. financial markets
open. Management will provide a Company update and discuss the first quarter
results during a conference call on Thursday, May 10, 2007, at 9:00 a.m. EDT.
Investors and other interested parties may access the call as follows:
Date: Thursday, May 10, 2007
Time: 9:00 a.m. EDT
Telephone (U.S.): 800.435.1398
Telephone (international): 617.614.4078
Participant Passcode: 30377239
Webcast: http://www.memorypharma.com under the
"Investors" section
An audio replay of the conference call will be available from 11:00 a.m.
EDT on Thursday, May 10, 2007, until Thursday, May 17, 2007. To access the
replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and
enter pass code number 55643908. An audio replay of the conference call will
also be available under the "Investors" section of the Company's website
during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 05/03/2007
/CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura
Perry of Stern Investor Relations, Inc., +1-212-362-1200/
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA BIO MTC
SU: CCA
JB
-- NYTH109 --
1749 05/03/2007 16:10 EDT http://www.prnewswire.com
